drugset / Trial / NCT00493441
AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study was designed to find the optimum AVN944 dose to use in combination with gemcitabine in patients with pancreatic cancer and see if the combination of the 2 drugs was more effective for treating pancreatic cancer than using gemcitabine alone.
Timeline
- Start
- 2007-06
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVN944 | Small molecule | 150 mg | — |
| Subject | AVN944 | Small molecule | 200 mg | — |
| Subject | AVN944 | Small molecule | 250 mg | — |
| Subject | AVN944 | Small molecule | 300 mg | — |
| Subject | AVN944 | Small molecule | 400 mg | — |